http://www.bicycletherapeutics.com
Bicycle Therapeutics is developing a platform technology to create a new generation of biotherapeutics combining features of small molecules and biopharmaceuticals to create highly specific and highly stable drugs.Bicycle Therapeutics is a spin-out from the Medical Research Council Laboratory of Molecular Biology, Cambridge, based on the work of the founding scientists Sir Gregory Winter and Dr.Christian Heinis.
BioRelix discovers and develops antibiotics that target pathogens resistant to currently available drugs by using novel patented bacterial RNA targets called “RiboSwitches™”